Clinical trial NCT01826981 - References

Chronic Hepatitis C — Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

Citation(s)

•   Gane EJ, Hyland RH, An D, Svarovskaia E, Pang PS, Brainard D, Stedman CA
  Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection. Gastroenterology. 2015 Nov;149(6):1454-1461.e1. doi: 1
•   Gane EJ, Hyland RH, An D, Svarovskaia ES, Brainard D, McHutchison JG
  Ledipasvir and sofosbuvir for HCV infection in patients coinfected with HBV. Antivir Ther. 2016;21(7):605-609. doi: 10.3851/IMP3066. Epub 2016 Jul 1.

A Phase 2, Multicenter, Open-Label Study to Assess the Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection

Details for clinical trial NCT01826981